Of note, one participant (P4) did not agree with any of the other participants in case of stromal P4HA2 expression with a cut-off of 60% (K = 0 for all participants), since P4 rated all DCIS cases as having less than 60% of stromal P4HA2 expression. Here, P4HA2 is linked to ductal breast carcinoma in situ.